TEL : +44 (0) 1865 854 888EMAIL : email@example.com
First User Evaluation - breath acetone device...
OMD's technology featured in Reuters video...
OMD wins NHS SBRI contract...
Research from OMD featured in Oxford Science Blog...
View All News
Oxford Medical Diagnostics is currently developing a first generation OMD Breath AnalyserTM which applies proprietary Cavity Enhanced Absorption Spectroscopy technology to the quantitative detection of acetone in human breath. Initial applications centre on the rapid, cost-effective, and reliable non-invasive monitoring for fat-loss and diabetic ketoacidosis.
Ian Campbell Chief Executive Officer Oxford Medical Diagnostics Centre for Innovation & Enterprise Oxford University Begbroke Science Park Sandy Lane Yarnton Oxford OX5 1PF Tel: 01865 854888 Email: firstname.lastname@example.org
Tel: +44 (0) 1865 854 888 - email: email@example.com
Oxford Medical Diagnostics Ltd, Centre for Innovation & Enterprise, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, OX5 1PF
Registered in England - Registered no. 06611677 - VAT No 935 9732 82
Content Management System By Fast Floor Multimedia